Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue
Copenhagen, Denmark, 20 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP)This announcement constitutes inside information that Brain+ A/S is obliged to make public pursuant to the EU Market Abuse Regulation (EU no. 596/2014). The information was submitted for publication by the contact person below on 20 June 2024. Brain+ A/S (“Brain+” or the “Company”) announces that the Company has agreed to expand the top-down guarantee tranche in its ongoing rights issue of units (new shares and warrants of series TO 4) of up to DKK 8.94 million (the “Rights Issue”). The expansion is to accommodate